D., Bedorf, N., Brigelius-Flohe, R., Schomburg, D
Neuropsychiatric disease and treatment
This includes questions about the appropriate diluent type and volume, needle size, injection technique, or dose measurement
Intense competition among established players creates pricing pressures and margin constraints
Early intervention and management of B12 deficiencies are key to maintaining healthy bodily function
The Revolution in Obesity Treatment: Before GLP-1 Medications: Diet and exercise alone: 3-5% sustained weight loss Older medications: 3-7% weight loss Bariatric surgery: 15-30% weight loss Gap between medication and surgery After GLP-1 Medications: Semaglutide: 10-15% weight loss Tirzepatide: 15-22% weight loss Bridge the gap with non-surgical option Results rival some bariatric procedures GLP-1 therapy has fundamentally changed whats possible with medical weight loss treatment